Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review
Frontiers in Oncology · 26.08.2024 · 14
DOI: 10.3389/fonc.2024.1402837 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 26.08.2024. Verfasst von Yingzhe Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lymphocyte activation gene 3 (LAG-3), also known as CD223, is an emerging immune checkpoint that follows PD-1 and CTLA-4. Several LAG-3 targeting inhibitors in clinical trials and the combination of relatlimab (anti-LAG-3) and nivolumab (anti-PD-1) have been approved for treating - unresectable or metastatic melanoma. Despite the encouraging clinical potential of LAG-3, the physiological function and mechanism of action in tumors are still not well understood. In this review, we systematically summarized the structure of LAG-3, ligands of LAG-3, cell-specific functions and signaling of LAG-3, and the current status of LAG-3 inhibitors under development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
- Department of Abdominal Oncology, Division of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zitieren
APA
Luo, Y., Cai, X., Yang, B., Lu, F., Yi, C., & Wu, G. (2024). Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1402837
Vancouver
Luo Y, Cai X, Yang B, Lu F, Yi C, Wu G. Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1402837
BibTeX
@article{Luo2024,
author = {Luo, Yingzhe and Cai, Xuebin and Yang, Biao and Lu, Facheng and Yi, Cheng and Wu, Guoyu},
title = {Advances in understanding the role of immune checkpoint LAG-3 in tumor immunity: a comprehensive review},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1402837}
}
EUVIMED